Increase of the striatal serotonergic fibers after nigrostriatal dopaminergic denervation in adult rats

International Congress Series

Volumn 1251, Issue C, 2003, Pages 211-215

  Maeda, Tetsuya ^a   Kannari, Kazuya ^a   Huo, Shen ^a   Arai, Akira ^a   Tomiyama, Masahiko ^a   Matsunaga, Muneo ^a   Suda, Toshihiro ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

6 Hydroxydopamine; Dopaminergic denervation; Immunohistochemistry; Parkinson's disease; Serotonergic hyperinnervation

Indexed keywords

EID: 80053364315     PISSN: 05315131     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0531-5131(03)00108-0     Document Type: Article

References (14)

1. Breese, G.R., Baumeister, A.A., McCown, T.J., Emerick, S.G., Frye, G.D., Crotty, K., Mueller, R.A., Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine. J. Pharmacol. Exp. Ther. 231 (1984), 343–354.
2. Breese, G.R., Duncan, G.E., Napier, T.C., Bondy, S.C., Iorio, L.C., Mueller, R.A., 6-Hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding. J. Pharmacol. Exp. Ther. 240 (1987), 167–176.
3. Bruno, J.P., Jackson, D., Zigmond, M.J., Stricker, E.M., Effects of dopamine-depleting brain lesions in rat pups: role of striatal serotonergic neurons in behavior. Behav. Neurosci. 101 (1987), 806–811.
4. El Mansari, M., Radja, F., Ferron, A., Reader, T.A., Molina-Holgado, E., Descarries, L., Hypersensitivity to serotonin and its agonists in serotonin-hyperinnervated neostriatum after neonatal dopamine denervation. Eur. J. Pharmacol. 261 (1994), 171–178.
5. Guerra, M.J., Liste, I., Labandeira-Garcia, J.L., Effects of lesions of the nigrostriatal pathway and of nigral grafts on striatal serotonergic innervation in adult rats. NeuroReport 8 (1997), 3485–3488.
6. Kannari, K., Tanaka, H., Maeda, T., Tomiyama, M., Suda, T., Matsunaga, M., Reserpine pretreatment prevents increases in extracellular striatal dopamine following L-DOPA administration in rats with nigrostriatal denervation. J. Neurochem. 74 (2000), 263–269.
7. Kannari, K., Yamato, H., Shen, H., Tomiyama, M., Suda, T., Matsunaga, M., Activation of 5-HT1A but not 5-HT1B receptors attenuates an increase in extracellular dopamine derived from exogenously administered L-DOPA in the striatum with nigrostriatal denervation. J. Neurochem. 76 (2001), 1346–1353.
8. Maeda, T., Kannari, K., Suda, T., Matsunaga, M., Loss of regulation by presynaptic dopamine D2 receptors of exogenous L-DOPA-derived dopamine release in the dopaminergic denervation striatum. Brain Res. 817 (1999), 185–191.
9. Snyder, A.M., Zigmond, M.J., Lund, R.D., Sprouting of serotonergic afferents into striatum after dopamine-depleting lesions in infant rats: a retrograde transport and immunocytochemical study. J. Comp. Neurol. 245 (1986), 274–281.
10. Stachowiak, M.K., Bruno, J.P., Snyder, A.M., Stricker, E.M., Zigmond, M.J., Apparent sprouting of striatal serotonergic terminals after dopamine-depleting brain lesions in neonatal rats. Brain Res. 291 (1984), 164–167.
11. Takeuchi, Y., Sawada, T., Blunt, S., Jenner, P., Marsden, C.D., Effects of 6-hydroxydopamine lesions of the nigrostriatal pathway on striatal serotonin innervation in adult rats. Brain Res. 562 (1991), 301–305.
12. Tanaka, Y., Kannari, K., Maeda, T., Tomiyama, M., Suda, T., Matsunaga, M., Role of serotonergic neurons in L-DOPA-derived extracellular dopamine in the striatum of 6-OHDA-lesioned rats. NeuroReport 10 (1999), 631–634.
13. Yamato, H., Kannari, K., Shen, H., Suda, T., Matsunaga, M., Fluoxetine reduces L-DOPA-derived extracellular DA in the 6-OHDA-lesioned rat striatum. NeuroReport 12 (2001), 1123–1126.
14. Zhou, F.C., Bledsoe, S., Murphy, J., Serotonergic sprouting is induced by dopamine-lesion in substantia nigra of adult rat brain. Brain Res. 556 (1991), 108–116.